1,407 results on '"Nobili, Valerio"'
Search Results
52. Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics
53. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
54. The relationship between body mass index and children’s presentations to a tertiary pediatric emergency department
55. Non-alcoholic fatty liver disease
56. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
57. Update on lipid species and paediatric nonalcoholic fatty liver disease
58. The Use of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: Teachable Moment or Missed Opportunity?
59. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
60. Nonalcoholic Fatty Liver in Children and Adolescents: An Overview
61. Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis
62. The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD)
63. Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments
64. Hepatitis B virus infection in children
65. Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD)
66. Association between nocturnal blood pressure dipping and insulin resistance in children affected by NAFLD
67. NASH and the Cross-Talk Between the Gut and Liver
68. Docosahexaenoic Acid and Its Role in G-Protein-Coupled Receptor 120 Activation in Children Affected by Nonalcoholic Fatty Liver Disease
69. Liver fibrosis in paediatric liver diseases
70. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease
71. Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease
72. A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis
73. Clinical Course Of Infection With Hepatitis C: Is Still Poorly Understood
74. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials
75. The rs2294918 E434K Variant Modulates Patatin-Like Phospholipase Domain-Containing 3 Expression and Liver Damage
76. Portal Inflammation Is Independently Associated With Fibrosis and Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease
77. The authorʼs reply: Pancreatic fat and hepato-metabolic features in obese children with nonalcoholic fatty liver disease
78. Targeting FGF19 binding to its receptor system: A novel therapeutic approach for hepatocellular carcinoma
79. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease
80. Altered gut–liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver
81. Vitamin D and liver fibrosis: letʼs start soon before itʼs too late
82. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
83. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
84. Zinc and Treatment of Wilson’s Disease
85. Association between type two diabetes and non-alcoholic fatty liver disease in youth
86. Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease
87. La steatosi epatica in età pediatrica: è parte intégrante della sindrome metabolica?: Proposto da Marco Cappa
88. Nonalcoholic fatty liver disease and atherosclerosis
89. Celiac Disease in Pediatric Patients with Autoimmune Hepatitis: Etiology, Diagnosis, and Management
90. Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal
91. Transient elastography for assessment of fibrosis in paediatric liver disease
92. Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study
93. Paediatric non-alcoholic fatty liver disease
94. Insulin-Like Growth Factor-I and -II Levels Are Associated with the Progression of Nonalcoholic Fatty Liver Disease in Obese Children
95. Management of chronic hepatitis B in children: An unresolved issue
96. Insulin-like growth factors (IGF-I and -II): new actors in the development of non-alcoholic fatty liver disease
97. Commentary: FGF21 Holds Promises for Treating Obesity-related Insulin Resistance and Hepatosteatosis
98. Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease
99. Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease
100. Obstructive Sleep Apnea Syndrome Affects Liver Histology and Inflammatory Cell Activation in Pediatric Nonalcoholic Fatty Liver Disease, Regardless of Obesity/Insulin Resistance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.